PT777483E - Metodos e meio para administrar farmacos - Google Patents

Metodos e meio para administrar farmacos

Info

Publication number
PT777483E
PT777483E PT95930761T PT95930761T PT777483E PT 777483 E PT777483 E PT 777483E PT 95930761 T PT95930761 T PT 95930761T PT 95930761 T PT95930761 T PT 95930761T PT 777483 E PT777483 E PT 777483E
Authority
PT
Portugal
Prior art keywords
pct
nerve head
sec
drug
methods
Prior art date
Application number
PT95930761T
Other languages
English (en)
Inventor
Johan Stjernschantz
Goran Selan
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of PT777483E publication Critical patent/PT777483E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT95930761T 1994-08-24 1995-08-24 Metodos e meio para administrar farmacos PT777483E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402816A SE9402816D0 (sv) 1994-08-24 1994-08-24 Method and meams for drug administration

Publications (1)

Publication Number Publication Date
PT777483E true PT777483E (pt) 2003-09-30

Family

ID=20395002

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95930761T PT777483E (pt) 1994-08-24 1995-08-24 Metodos e meio para administrar farmacos

Country Status (12)

Country Link
US (1) US5952378A (pt)
EP (1) EP0777483B1 (pt)
JP (1) JPH10507743A (pt)
AT (1) ATE238799T1 (pt)
AU (1) AU3402295A (pt)
CA (1) CA2198245C (pt)
DE (1) DE69530594T2 (pt)
DK (1) DK0777483T3 (pt)
ES (1) ES2199253T3 (pt)
PT (1) PT777483E (pt)
SE (1) SE9402816D0 (pt)
WO (1) WO1996005840A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7708711B2 (en) 2000-04-14 2010-05-04 Glaukos Corporation Ocular implant with therapeutic agents and methods thereof
US7867186B2 (en) 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
ES2304438T3 (es) 2001-04-07 2008-10-16 Glaukos Corporation Stent de glaucoma para el tratamiento del glaucoma.
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US20040198829A1 (en) * 2001-04-23 2004-10-07 Sponsel William Eric Prostanoids augment ocular drug penetration
US7678065B2 (en) 2001-05-02 2010-03-16 Glaukos Corporation Implant with intraocular pressure sensor for glaucoma treatment
AU2002305400A1 (en) 2001-05-03 2002-11-18 Glaukos Corporation Medical device and methods of use for glaucoma treatment
US20040192699A1 (en) * 2001-07-02 2004-09-30 Santen Pharmaceutical Co., Ltd. Optic nerve protecting agents containing alpha1 receptor blocker as active ingredient
US7331984B2 (en) 2001-08-28 2008-02-19 Glaukos Corporation Glaucoma stent for treating glaucoma and methods of use
US7163543B2 (en) * 2001-11-08 2007-01-16 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US7759333B2 (en) 2001-12-14 2010-07-20 Alcon, Inc. Superoxide dismutase mimics for the treatment of ocular disorders and diseases
US20030113270A1 (en) * 2001-12-14 2003-06-19 Clark Abbot F. Vasoactive intestinal peptides for glaucomatous retinopathy
US7951155B2 (en) 2002-03-15 2011-05-31 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US9301875B2 (en) 2002-04-08 2016-04-05 Glaukos Corporation Ocular disorder treatment implants with multiple opening
EP1539066B1 (en) * 2002-09-17 2012-11-07 Iscience Surgical Corporation Apparatus surgical bypass of aqueous humor
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
EP1663230A1 (en) * 2003-09-05 2006-06-07 Novartis AG Compositions comprising benzo(g)quinoline derivatives and prostaglandin derivatives
AU2004305531B2 (en) * 2003-12-11 2009-11-26 Alcon, Inc. Superoxide dismutase mimics for the treatment of optic nerve and retinal damage
EP2471563A1 (en) * 2004-04-29 2012-07-04 iScience Interventional Corporation Apparatus and method for surgical enhancement of aqueous humor drainage
US8322350B2 (en) 2004-12-30 2012-12-04 Philip Morris Usa Inc. Aerosol generator
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
WO2007101204A1 (en) * 2006-02-27 2007-09-07 Alcon Research, Ltd. Method of treating glaucoma
WO2008061043A2 (en) 2006-11-10 2008-05-22 Glaukos Corporation Uveoscleral shunt and methods for implanting same
AU2008296908B2 (en) * 2007-09-05 2014-01-09 Teva Pharmaceutical Industries, Ltd. Method of treating glaucoma using rasagiline
US8425473B2 (en) 2009-01-23 2013-04-23 Iscience Interventional Corporation Subretinal access device
US20100191177A1 (en) * 2009-01-23 2010-07-29 Iscience Interventional Corporation Device for aspirating fluids
JP5342301B2 (ja) * 2009-03-30 2013-11-13 三菱重工業株式会社 太陽光集光受熱器
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
JP5996544B2 (ja) 2010-10-15 2016-09-21 クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ 眼球アクセス用装置
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
WO2013040079A1 (en) 2011-09-13 2013-03-21 Dose Medical Corporation Intraocular physiological sensor
KR20210133321A (ko) 2012-11-08 2021-11-05 클리어사이드 바이오메디컬, 인코포레이드 인간 대상체에서 안구 질병을 치료하기 위한 방법 및 장치
US9730638B2 (en) 2013-03-13 2017-08-15 Glaukos Corporation Intraocular physiological sensor
EP4378444A3 (en) 2013-05-03 2024-07-03 Clearside Biomedical, Inc. Apparatus and methods for ocular injection
EP3003454B1 (en) 2013-06-03 2020-01-08 Clearside Biomedical, Inc. Apparatus for drug delivery using multiple reservoirs
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
EP3148491B1 (en) 2014-05-29 2020-07-01 Glaukos Corporation Implants with controlled drug delivery features and manufacturing method for said implants
CN106794321A (zh) 2014-06-20 2017-05-31 科尼尔赛德生物医学公司 可变直径插管以及用于控制对药剂递送的插入深度的方法
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
EP3413851B1 (en) 2016-02-10 2023-09-27 Clearside Biomedical, Inc. Packaging
CN115120405A (zh) 2016-04-20 2022-09-30 多斯医学公司 生物可吸收眼部药物的递送装置
EP3452165A1 (en) 2016-05-02 2019-03-13 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
IL305537A (en) 2016-08-12 2023-10-01 Clearside Biomedical Inc Devices and methods for adjusting the insertion depth of a drug administration needle
WO2018204515A1 (en) 2017-05-02 2018-11-08 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.

Also Published As

Publication number Publication date
SE9402816D0 (sv) 1994-08-24
CA2198245A1 (en) 1996-02-29
JPH10507743A (ja) 1998-07-28
WO1996005840A1 (en) 1996-02-29
CA2198245C (en) 2003-06-17
EP0777483B1 (en) 2003-05-02
DK0777483T3 (da) 2003-08-25
US5952378A (en) 1999-09-14
DE69530594D1 (de) 2003-06-05
EP0777483A1 (en) 1997-06-11
ATE238799T1 (de) 2003-05-15
DE69530594T2 (de) 2004-03-18
AU3402295A (en) 1996-03-14
ES2199253T3 (es) 2004-02-16

Similar Documents

Publication Publication Date Title
PT777483E (pt) Metodos e meio para administrar farmacos
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
IT1274879B (it) Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
ATE207352T1 (de) Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
DK0850068T3 (da) Lipidekstrakt med antiinflammatorisk aktivitet
BR0212809A (pt) Inibidores de anticorpos de gdf-8 e usos dos mesmos
AU7814498A (en) Multivalent (in ovo) avian vaccine
BG102064A (en) Method for increasing the retinal blood circulation
DK0871446T3 (da) Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve
SE9403160D0 (sv) Method and means for prevention and treatment of secondary cataract
EE9700068A (et) Selegiliini kasutamine epileptiliste haiguste raviks
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
AU4530796A (en) Treating disorders characterised by excessive cell proliferation with sclareolide
HRP20080389A2 (en) THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS